Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Experts urge early detection & better access to care
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Announces Rs. 317 crore investment in new recycling plant
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Overall investment in the US facility is estimated around US$50 million
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Subscribe To Our Newsletter & Stay Updated
